Tuesday, July 1, 2008

Wormgadget: Hookworm Allergy Treatment

Filed under: in the news...


New York Times has an article today on medicine's favorite kind of researcher: the self-infecting scientist. Scientists throughout history have made amazing discoveries by intentionally infecting themselves with deadly pathogens. Stories are often told of the brazen heroics of John Hunter giving himself gonorrhea and syphilis, or even more recently of Barry Marshall drinking a concoction of H. Pylori to prove that it caused gastritis.

The latest in this distinguished line of masochistic research is Dr. David Pritchard. In his past research. Dr. Pritchard noticed that people infected with hookworms didn't seem to suffer from asthma and hay fever as much as non-infected individuals. His testing in animal models produced unpredictable results, leading him to the conclusion that the only way to do this right would be to let 50 or so worms crawl in through his skin quite painfully. The pain and diarrhea that followed changed the recommended worm dose from 50 to 10.

The aspect of our immune system that is responsible for getting rid of these types of parasites is also responsible for many allergies and auto-immune diseases. While the worms sit in your small bowel, happily sucking your blood from the inside, it is believed that they produce substances that suppress this allergy causing wing of the immune system.

The research is currently testing the plausibility of this theory. The over-arching goal is to identify the suppressing substance and synthesize it as a drug. However, people are a bit impatient and are paying up to $3000 dollars to have worms crawl through their skin.

Read the entertaining article here...

email this article to a friend      print this!           comments and peer reviews (1)






replies: 1 comments
Open comments are not moderated, although abusive and vulgar remarks may be deleted. Opinions expressed do not necessarily reflect the views of Medgadget.com. Please consult our disclaimer.

There is already a potential therapeutic in early stages of development that works via the same mechanism. The company involved is a small New Zealand firm called Virionyx, whose scientific founder was developing a microparticle composed of bacterial peptides as a vaccine adjuvant and found that when used as a single agent, it elicited a strong innate immune response. When the scientist developed an autoimmune disease, he tried the microparticule on himself and saw it down regulate his disease symptoms, just as the worms down-regulated them in Dr. Pritchard's research. Virionyx is now looking for development partners to take this work further.


Posted by:
on July 1, 2008 04:16 PM GMT

add a comment
html tags: <b>, <i>, and <a>
examples: <b>Bold</b> <i>Italic</i>









Remember personal info?
(anonymous comments allowed)



click to make your selection boldclick to make your selection italicclick to add a link


Verification (needed to reduce spam):




Click the "Post" button only once!